IP Library Granted Patent US 10,722,282
Granted Patent B2
US 10,722,282 · App. 16/041,101 · Granted Jul 28, 2020

Methods and devices to treat nasal airways

Inventors: Scott J. Wolf (Menlo Park, CA); Andrew Frazier (Sunnyvale, CA)
Assignee: AERIN MEDICAL, INC.
A61B18/02A61B5/01A61B17/24A61B17/2816A61B18/06A61B18/085A61B18/1206A61B18/14A61B18/1442A61B18/1445A61B18/1477A61B18/1485A61B18/16A61F5/08A61F5/56A61F7/10A61N1/403A61N5/025A61N5/0603A61N5/0625A61B17/320068A61B18/1815A61B18/20A61B2017/248A61B2018/00005A61B2018/0016A61B2018/0022A61B2018/00023A61B2018/0091A61B2018/00178A61B2018/00327A61B2018/00434A61B2018/00577A61B2018/00595A61B2018/00642A61B2018/00702A61B2018/00708A61B2018/00791A61B2018/00821A61B2018/00875A61B2018/00886A61B2018/00922A61B2018/00928A61B2018/00982A61B2018/00994A61B2018/0212A61B2018/0225A61B2018/0262A61B2018/044A61B2018/126A61B2018/1253A61B2018/143A61B2018/1425A61B2018/1467A61B2018/1807A61B2018/1861A61N7/022F04C2270/041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,722,282
App. No.
16/041,101
Granted
Jul 28, 2020
Kind
B2
Abstract

A method for reshaping a nasal airway in a patient involves advancing an inflatable balloon of a reshaping device in an uninflated configuration into a nostril of the patient and between a nasal septum and a lateral wall of the nasal airway. The method then involves inflating the inflatable balloon to an inflated configuration to cause the inflatable balloon to contact nasal mucosa covering the nasal septum and the lateral wall, delivering energy from an energy delivery member attached to or inside of the inflatable balloon, and removing the reshaping device from the nasal airway.

Claims (17)

1. A system for treating a nasal airway in a patient, without forming an incision, penetrating tissue with a needle, or leaving behind an implant, the system comprising:

a nasal airway treatment device, comprising;

a treatment element, comprising;

an inflatable balloon configured to be advanced into the nasal airway in an uninflated configuration and inflated to assume an inflated configuration; and

multiple longitudinal, flat, expandable, bipolar radiofrequency electrodes disposed on an outer surface of the inflatable balloon around a full circumference of the inflatable balloon at regular intervals, wherein each of the radiofrequency electrodes comprises a conductive metal configured to bend outward with the inflatable balloon when the inflatable balloon expands;

a shaft attached to a proximal end of the treatment element; and

a handle attached to a proximal end of the shaft;

a controller coupled with the nasal airway treatment device to control delivery of radiofrequency energy to the nasal airway via the multiple radiofrequency electrodes; and

a radiofrequency energy generator coupled with the nasal airway treatment device to provide the radiofrequency energy to the multiple radiofrequency electrodes.

2. The system of claim 1 , further comprising wiring configured to carry radiofrequency energy from the radiofrequency energy generator to the multiple radiofrequency electrodes.

3. The system of claim 1 , further comprising a pharmaceutical substance coated on or contained within the inflatable balloon, wherein the inflatable balloon is configured to release the pharmaceutical substance within the nasal airway.

4. The system of claim 1 , wherein the shaft comprises:

an outer shaft; and

an inner shaft that extends through an interior of the inflatable balloon, wherein a proximal end and a distal end of the inflatable balloon are attached to the inner shaft, and wherein the inner shaft comprises an inflation lumen and at least one inflation aperture for inflating the inflatable balloon.

5. The system of claim 1 , wherein the controller is housed in the handle.

6. The system of claim 1 , wherein the handle comprises a power button to activate delivery of the radiofrequency energy from the radiofrequency energy generator to the at least one radiofrequency electrode.

7. The system of claim 1 , wherein the controller and the radiofrequency generator are housed in one console that is coupled with the nasal airway treatment device, and wherein the nasal airway treatment device further comprises a cable attached to the handle to connect the nasal airway treatment device with the console.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2024
From: CRG SERVICING LLC
To: AERIN MEDICAL INC.
Reel/Frame 069654/0467 →
SECURITY INTEREST Recorded Dec 20, 2024
From: AERIN MEDICAL INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 069746/0508 →
SECURITY INTEREST Recorded May 13, 2019
From: AERIN MEDICAL INC.
To: CRG SERVICING LLC
Reel/Frame 049161/0043 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2018
From: WOLF, SCOTT J.; FRAZIER, ANDREW
To: AERIN MEDICAL, INC.
Reel/Frame 047039/0565 →
Continuity (7)
Continuation In Part 15480575 · Apr 6, 2017
Continuation 15380812 · Dec 15, 2016
Continuation 14963719 · Dec 9, 2015
Continuation 13495879 · Jun 13, 2012
Provisional Application 61496930 · Jun 14, 2011
Provisional Application 61603864 · Feb 27, 2012
Related Publication 20180344378A1 · Dec 6, 2018
Cited By (14)
US 12,336,750 US 12,357,378 US 12,357,817 US 12,364,532 US 12,369,963 US 12,369,966 US 12,369,973 US 12,471,978 US 12,484,946 US 12,527,618 US 12,636,058 US 12,636,073 US 12,678,212 US 12,690,907